about
Human Heredity and Health (H3) in Africa Kidney Disease Research Network: A Focus on Methods in Sub-Saharan AfricaSocial Determinants of Racial Disparities in CKD.The impact of short stature on health-related quality of life in children with chronic kidney diseaseThe RIVUR trial: a factual interpretation of our dataEnd-stage renal disease in two pediatric patients with Fechtner syndrome.Pediatric kidney disease: tracking onset and improving clinical outcomes.Glomerular disease: looking beyond pathology.Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study.Development and impact of an intervention to boost recruitment in a multicenter pediatric randomized clinical trial.Research capacity. Enabling the genomic revolution in Africa.Medication adherence and growth in children with CKD.Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference.Kidney function in severely obese adolescents undergoing bariatric surgery.The association between abnormal birth history and growth in children with CKD.Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.Regulatory aspects of noninvasive glucose measurements.Controversies in the management of vesicoureteral reflux: the rationale for the RIVUR studyProgression of pediatric CKD of nonglomerular origin in the CKiD cohort.Protein energy wasting in children with chronic kidney disease.Therapeutic approach to FSGS in children.Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical TrialKidney volume and functional outcomes in autosomal dominant polycystic kidney disease.Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney diseasePredictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort.Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin CHyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.CKiD (CKD in children) prospective cohort study: a review of current findings.Patient recruitment into a multicenter randomized clinical trial for kidney disease: report of the focal segmental glomerulosclerosis clinical trial (FSGS CT).Recurrent Urinary Tract Infections in Children With Bladder and Bowel Dysfunction.Complete Remission in the Nephrotic Syndrome Study Network.Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) TrialRenal function and proteinuria after successful immunosuppressive therapies in patients with FSGS.Neurocognitive outcomes in children with chronic kidney disease: Current findings and contemporary endeavors.Association of histologic variants in FSGS clinical trial with presenting features and outcomesHemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study.Predictors of Antimicrobial Resistance among Pathogens Causing Urinary Tract Infection in Children.Antimicrobial Resistance and Urinary Tract Infection Recurrence.Factors that influence parental decisions to participate in clinical research: consenters vs nonconsenters.The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux.Genomic approaches to the burden of kidney disease in Sub-Saharan Africa: the Human Heredity and Health in Africa (H3Africa) Kidney Disease Research Network
P50
Q28606687-5628EFDA-5810-4EC3-865A-E7A39C6FA90BQ30250319-157B5698-C1EB-4424-88B6-C277032360CAQ30411058-F3D3DA82-980E-49B6-89B7-1DE4130B455BQ30882767-5AADC92F-8D4E-4115-8B28-EBB5556913A8Q33330962-911F3650-AE23-454A-BBD1-BE6F047B049DQ33715765-6117D151-8F36-46F9-B050-63F7D628CCA8Q33715776-FE993691-91E0-4A79-9F4B-A062C9649F21Q33741119-E75C15CF-13BF-4281-8735-D33248899525Q33861791-8CFBF4F7-B488-4E4F-B966-4FBF2AB7DDC4Q34068017-2DDAD8C7-B8B6-4876-A708-E79AB2C60165Q34124705-193036CE-294A-46B8-AEBE-13B91751AFC9Q34428848-3D100F01-CCCB-4BCC-A3EF-AC5543C03444Q34478306-B88FAE96-B76E-4BD6-BBDA-F00B29B83922Q34497192-E383F58B-EC2B-417F-BBAD-F88C73C66F5CQ34858052-E3C3B35D-C160-4B53-9025-D34CCAE7B8E2Q35103310-ED380FFF-B5BB-4F8E-8E04-1A30D9224E71Q35184683-4F6E9276-929D-4F05-BB35-E4965E6D47CBQ35278515-BD7A41BE-084E-4949-B2EE-55073FD27BF3Q35553088-842C5ADC-3EAA-495D-88B4-80F00ED6CCCBQ35614311-BE0C96AD-C3A9-4C79-B1EA-2E6AED764B6DQ35658566-0B8E229F-55BC-4739-BCB9-75463DC79B0CQ35827271-1FB965E5-0010-4C47-91A2-0A37BFA219DCQ35983445-4E35D0EA-0A83-4109-89D0-D66BAB7FFEE4Q36083206-44DBEEAC-4039-47B4-AA78-C815A7D44A9EQ36207827-D6F393EE-AC5C-46A6-9CF5-6F6C1420E40EQ36315937-016F56BD-E33A-4E12-918B-54EACE11F07CQ36392732-F1AB7756-9555-4896-9EF2-63BD0A69EC27Q36423823-FF6E28DB-29A5-4E03-83F2-0F66A6C20AC7Q36432192-9BB9536D-CBB5-4F14-A810-A78179FABDD4Q36432859-FF5EAA37-5CF0-4BDD-99FC-CD52435DC0B4Q36432920-9B5748F4-E3CB-441B-907A-60926B1500AAQ36583388-B8946436-AA00-438A-8A6E-78CC29E4526AQ36633256-96225F59-F226-4EF2-BC80-5F875290BCA6Q36652814-A08198A0-48A2-48F5-AA41-3E1E122EF2CBQ36666815-1C03797E-E4E7-4C00-9E3F-391C90BA2900Q36731363-E44C9069-E65F-43FD-B8CF-133DBC923B53Q36738347-5F5871A1-7C16-417A-A535-CC53A437E617Q36906502-EC2A97D4-49F8-4516-BBF1-DE66B1752ADBQ36952219-2AFD0480-8ED0-4B14-9DA4-104ABF97EFE3Q37191043-611B8049-9C94-4B4D-B366-C5C0116ED7F6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marva Moxey-Mims
@ast
Marva Moxey-Mims
@en
Marva Moxey-Mims
@es
Marva Moxey-Mims
@nl
type
label
Marva Moxey-Mims
@ast
Marva Moxey-Mims
@en
Marva Moxey-Mims
@es
Marva Moxey-Mims
@nl
prefLabel
Marva Moxey-Mims
@ast
Marva Moxey-Mims
@en
Marva Moxey-Mims
@es
Marva Moxey-Mims
@nl
P106
P31
P496
0000-0001-8542-9313